Back
Innovent Biologics 10K Form
Sell
28
IVBIY
Innovent Biologics
Last Price:
19.15
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IVBIY News And Ratings
See the #1 stock for the next 7 days that we like better than IVBIY
IVBIY Financial Statistics
Sales & Book Value
| Annual Sales: | $877.36M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.20 |
| Price / Book: | 4.56 |
Profitability
| EPS (TTM): | -0.45020 |
|---|---|
| Net Income (TTM): | $-178.06M |
| Gross Margin: | $716.72M |
| Return on Equity: | -10.76% |
| Return on Assets: | -6.54% |
Innovent Biologics Earnings Forecast
Key Innovent Biologics Financial Ratios
- The Gross Profit Margin over the past 6 years for IVBIY is 81.69%.
- The Selling, General & Administrative Expenses for IVBIY have been equal to 62.05% of Gross Profit Margin.
- The Research & Development expenses have been 35.89% of Revenue.
- The Interest Expense is -9.59% of Operating Income.
- The Net Earning history of IVBIY is -16.56% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 4 years.
Innovent Biologics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Current Symbol: | IVBIY |
| Website: | innoventbio.com |
Debt
| Debt-to-Equity Ratio: | 0.26 |
|---|---|
| Current Ratio: | 2.68 |
| Quick Ratio: | 2.46 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IVBIY Technical Analysis vs Fundamental Analysis
Sell
28
Innovent Biologics (IVBIY)
is a Sell
Is Innovent Biologics a Buy or a Sell?
-
Innovent Biologics stock is rated a Sell
The current Innovent Biologics [IVBIY] share price is $19.15. The Score for IVBIY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.